Nishant Singh

Dr. Nishant Singh

Absorption Systems (United States), Exton, Pennsylvania, USA
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
Debashis DuttaDebashis Dutta
Debashis Dutta
SNSarah Naiyer
Sarah Naiyer
SMSabanaz Mansuri
Sabanaz Mansuri
Neeraj SoniNeeraj Soni
Neeraj Soni
VANDANA SINGHVANDANA SINGH
VANDANA SINGH
MMMohammad Shahid Mansuri
Mohammad Shahid Mansuri
The world is grappling with the coronavirus disease 2019 (COVID-19) pandemic, the causative agent of which is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 symptoms are similar to the common cold, including fever, sore throat, cough, muscle and chest pain, brain fog, dyspnoea, anosmia, ageusia, and headache. The manifestation of the disease can vary from being asymptomatic to severe life-threatening conditions warranting hospitalization and ventilation support. Furthermore, the emergence of mutecated variants of concern (VOCs) is paramount to the devastating effect of the pandemic. This highly contagious virus and its emergent variants challenge the available advanced viral diagnostic methods for high-accuracy testing with faster result yields. This review is to shed light on the natural history, pathology, molecular biology, and efficient diagnostic methods of COVID-19, detecting SARS-CoV-2 in collected samples. We reviewed the gold standard RT-qPCR method for COVID-19 diagnosis to confer a better understanding and application to combat the COVID-19 pandemic. This comprehensive review may further develop awareness about the management of the COVID-19 pandemic.
1

1 October 2020 in Translational Oncology
Verified
Journal Article
Open access
NSNishant Singh
Nishant Singh
ASAnuradha Bharara Singh
Anuradha Bharara Singh
Novel coronavirus disease 2019 (COVID-19) is the biggest threat to human being globally. The first case was identified in a patient with flu symptoms along with severe acute respiratory syndrome in Wuhan, China in December 2019 and now it has spread in more than 200 countries. COVID-19 is more lethal in the elderly and people with an underlying condition such as asthma, cancer, diabetes. Here we performed bioinformatic analysis to investigate the interaction of S2 subunit protein of SARS-nCoV-2 of novel coronavirus with tumor suppressor proteins p53 and BRCA-1/2. In this short communication we report the interaction between S2 subunit proteins with tumor suppressor proteins for the first time. This preliminary result will open up a new direction to investigate the effect of a novel coronavirus in cancer patients.

30 September 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NSNishant Singh
Nishant Singh
ABAlok Bhattacharya
Alok Bhattacharya
SBSudha Bhattacharya
Sudha Bhattacharya
Homologous recombination (HR) has not been demonstrated in the parasitic protists Entamoeba histolytica or Entamoeba invadens, as no convenient method is available to measure it. However, HR must exist to ensure genome integrity, and possible genetic exchange, especially during stage conversion from trophozoite to cyst. Here we show the up regulation of mitotic and meiotic HR genes in Entamoeba during serum starvation, and encystation. To directly demonstrate HR we use a simple PCR-based method involving inverted repeats, which gives a reliable read out, as the recombination junctions can be determined by sequencing the amplicons. Using this read out, we demonstrate enhanced HR under growth stress in E. histolytica, and during encystation in E. invadens. We also demonstrate recombination between chromosomal inverted repeats. This is the first experimental demonstration of HR in Entamoeba and will help future investigations into this process, and to explore the possibility of meiosis in Entamoeba.

1 July 2016 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
NSNishant Singh
Nishant Singh
ASAnuradha Bharara Singh
Anuradha Bharara Singh

1 July 2015 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
SSSudeep Shukla
Sudeep Shukla
VAVikas Arora
Vikas Arora
AJAlka Jadaun
Alka Jadaun
JKJitender Kumar
Jitender Kumar
NSNishant Singh
Nishant Singh
VJVinod Kumar Jain
Vinod Kumar Jain
Amebiasis, a major health problem in developing countries, is the second most common cause of death due to parasitic infection. Amebiasis is usually transmitted by the ingestion of Entamoeba histolytica cysts through oral–fecal route. Herein, we report on the use of chitosan oligosaccharide-functionalized iron oxide nanoparticles for efficient capture and removal of pathogenic protozoan cysts under the influence of an external magnetic field. These nanoparticles were synthesized through a chemical synthesis process. The synthesized particles were characterized by transmission electron microscopy, Fourier transform infrared spectroscopy, X-ray diffraction, and zeta potential analysis. The particles were found to be well dispersed and uniform in size. The capture and removal of pathogenic cysts were demonstrated by fluorescent microscopy, transmission electron microscopy, and scanning electron microscopy (SEM). Three-dimensional modeling of various biochemical components of cyst walls, and thereafter, flexible docking studies demonstrate the probable interaction mechanism of nanoparticles with various components of E. histolytica cyst walls. Results of the present study suggest that E. histolytica cysts can be efficiently captured and removed from contaminated aqueous systems through the application of synthesized nanoparticles.

1 February 2011 in Experimental Parasitology
Verified
Journal Article
Closed access
NSNishant Singh
Nishant Singh
SBSudha Bhattacharya
Sudha Bhattacharya
JPJaishree Paul
Jaishree Paul